Twist Bioscience Corporation TWST Ratios & Valuation
| TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 52.1%+0.4pp | 51.6%+0.9pp | 50.7%+1.5pp | 49.2%+2.5pp | 46.7%+2.1pp | |
| Operating margin | -33.9%+0.5pp | -34.4%+1.8pp | -36.2%+3.1pp | -39.3%+18.6pp | -57.9%+5.3pp | |
| Net margin | -19.8%-0.3pp | -19.6%+1.1pp | -20.6%+2.9pp | -23.5%+31.5pp | -55%+4.8pp | |
| Returns | ||||||
| Return on equity | -18.2%-1.4pp | -16.8%-0.4pp | -16.4%+1.1pp | -17.6%+20.6pp | -38.2%-0.5pp | |
| Return on invested capital | -36.4%-0.4pp | -36%+2.6pp | -38.6%+1.9pp | -40.5%+15.0pp | -55.4%+0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.5×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.7×-1.1× | 3.8×+0.1× | 3.6×-0.3× | 3.9×-0.6× | 4.5×-0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $7.38-1.2% | $7.47-5.6% | $7.91+1.1% | $7.82+6.0% | $7.38-4.3% | |
| Valuation | ||||||
| Market capitalization | $2.91B+50.2% | $1.94B+14.2% | $1.7B-20.9% | $2.15B-8.3% | $2.34B-15.1% | |
| Price / sales | 7.1×+2.2× | 5×+0.4× | 4.5×-1.4× | 5.9×-0.8× | 6.7×-1.6× | |
| Price / book | 6.4×+2.1× | 4.3×+0.7× | 3.6×-0.9× | 4.5×-0.8× | 5.3×-0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Twist Bioscience Corporation's profit margins?
- Twist Bioscience Corporation (TWST) runs a 52.1% gross margin and a -33.9% operating margin, with a -19.8% net margin.
- Where do Twist Bioscience Corporation's ratios come from?
- Every ratio is computed from Twist Bioscience Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.